Clinical Trial Update: Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluated budesonide for treating bronchial dysplasia in former and current smokers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Dysplasia
• Lung Cancer

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED